Who
Robert Eugene Watson
Director
Company insider
Files Form 4 as: Director, Cel-Sci; President & CEO, Streamline Health Solutions.
In numbers
- Trades disclosed
- 37
- Buys
- 14
- Sells
- 0
- Bought
- $345K
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 31 Jan 2011
- Last trade
- 14 Aug 2026
- Last filed
- 17 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 14 Aug 2026filed 17 Aug 2026 | CVM Cel-Scioption or derivative · Biotechnology | SEC FORM 4 Code A | $1,100110,000 at $0.01 | filing |
| 14 Aug 2026filed 17 Aug 2026 | CVM Cel-Scioption or derivative · Biotechnology | SEC FORM 4 Code A | $1,100110,000 at $0.01 | filing |
| 28 Jul 2025filed 29 Jul 2025 | CVM Cel-Scioption or derivative · Biotechnology | SEC FORM 4 Code A | $404,000 at $0.01 | filing |
| 25 Jul 2025filed 29 Jul 2025 | CVM Cel-SciBiotechnology | SEC FORM 4 Bought | $20K2,919 at $6.85 | filing |
| 8 May 2024filed 10 May 2024 | CVM Cel-SciBiotechnology | SEC FORM 4 Bought | $28K20,000 at $1.39 | filing |
| 19 Apr 2024filed 23 Apr 2024 | CVM Cel-Scioption or derivative · Biotechnology | SEC FORM 4 Code A | $64064,000 at $0.01 | filing |
| 8 Aug 2023filed 10 Aug 2023 | CVM Cel-Scioption or derivative · Biotechnology | SEC FORM 4 Code A | $64064,000 at $0.01 | filing |
| 13 Jun 2022filed 14 Jun 2022 | CVM Cel-Scioption or derivative · Biotechnology | SEC FORM 4 Code A | $64064,000 at $0.01 | filing |
| 6 Jul 2021filed 7 Jul 2021 | CVM Cel-SciBiotechnology | SEC FORM 4 Bought | $10K1,250 at $8.00 | filing |
| 14 May 2021filed 17 May 2021 | CVM Cel-Scioption or derivative · Biotechnology | SEC FORM 4 Code A | $1,280128,000 at $0.01 | filing |
| 18 Nov 2020filed 18 Nov 2020 | CVM Cel-SciBiotechnology | SEC FORM 4 Bought | $9,416800 at $11.77 | filing |
| 20 Apr 2020filed 20 Apr 2020 | CVM Cel-Scioption or derivative · Biotechnology | SEC FORM 4 Code A | $1,280128,000 at $0.01 | filing |
| 26 Feb 2020filed 27 Feb 2020 | CVM Cel-SciBiotechnology | SEC FORM 4 Bought | $9,996923 at $10.83 | filing |
| 7 May 2019filed 8 May 2019 | CVM Cel-SciBiotechnology | SEC FORM 4 Code A | $10K1,458 at $6.86 | filing |
| 11 Apr 2019filed 12 Apr 2019 | CVM Cel-Scioption or derivative · Biotechnology | SEC FORM 4 Code A | $1,600160,000 at $0.01 | filing |
| 1 May 2018filed 3 May 2018 | CVM Cel-Scioption or derivative · Biotechnology | SEC FORM 4 Code A | $80080,000 at $0.01 | filing |
| 18 Dec 2017filed 16 Jan 2018 | CVM Cel-Scioption or derivative · Biotechnology | SEC FORM 4 Code A | $10010,000 at $0.01 | filing |
| 20 Jan 2015filed 22 Jan 2015 | Streamline Health Solutions | SEC FORM 4 Bought | $8,8502,500 at $3.54 | filing |
| 8 Jan 2015filed 12 Jan 2015 | Streamline Health Solutions | SEC FORM 4 Code A | —59,244 at $0.00 | filing |
| 19 Sep 2014filed 22 Sep 2014 | Streamline Health Solutions | SEC FORM 4 Bought | $14K3,500 at $3.92 | filing |
News
No headline names them, or the companies they trade most, lately.